Literature DB >> 6119651

Ipecac-induced myopathy simulating dermatomyositis.

H S Bennett, A J Spiro, M A Pollack, P Zucker.   

Abstract

We studied a young woman with an eating disorder. To induce vomiting, she took syrup of ipecac daily for 2 years, and then developed insidious, progressive muscle weakness. Skin findings were similar to those of dermatomyositis. Muscle biopsy, however, was similar to experimental emetine myopathy and lacked inflammatory features. Upon cessation of ipecac abuse, strength returned. We believe that this patient had ipecac-induced muscle weakness.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6119651     DOI: 10.1212/wnl.32.1.91

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  The medical complications associated with purging.

Authors:  K Jean Forney; Jennifer M Buchman-Schmitt; Pamela K Keel; Guido K W Frank
Journal:  Int J Eat Disord       Date:  2016-02-15       Impact factor: 4.861

2.  Myopathy from surreptitious ipecac ingestion.

Authors:  N L Rosenberg; S P Ringel
Journal:  West J Med       Date:  1986-09

3.  Ultrastructural pathology in emetine-induced myopathy.

Authors:  L Halbig; L Gutmann; H H Goebel; J F Brick; S Schochet
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

4.  Ipecac myopathy and cardiomyopathy.

Authors:  L P Dresser; E W Massey; E E Johnson; E Bossen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

5.  Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy.

Authors:  T Kuntzer; J Bogousslavsky; J P Deruaz; R Janzer; F Regli
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.